title: Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy.
authors.affiliation: Department of Surgery, University of Pennsylvania, Medical Center, Philadelphia, USA.
authors.forename: M
authors.initials: M
authors.lastname: Weber
authors.forename: S
authors.initials: S
authors.lastname: Deng
authors.forename: J
authors.initials: J
authors.lastname: Arenas
authors.forename: S
authors.initials: S
authors.lastname: Aradhye
authors.forename: R
authors.initials: R
authors.lastname: Grossman
authors.forename: L
authors.initials: L
authors.lastname: Shaw
authors.forename: A
authors.initials: A
authors.lastname: Naji
authors.forename: C
authors.initials: C
authors.lastname: Barker
authors.forename: K L
authors.initials: KL
authors.lastname: Brayman
mesh_terms: D001741:Black or African American; D001379:Azathioprine / Q000627:therapeutic use; D044383:Black People; D002102:Cadaver; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D019520:Living Donors; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015143:Philadelphia; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use*; D014019:Tissue Donors; D044465:White People
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine; D016559:Tacrolimus